Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PHGDH | O43175 | 15/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17593034 | 0.93 | PHGDH (0.42) | PHGDHMAPT | |
| SCHEMBL17593251 | 0.91 | L3MBTL1 (0.40) | PHGDHNPC1RAB9AHPGDKDM4E | |
| SCHEMBL17592994 | 0.90 | KDM4E (0.40) | PHGDHNPC1RAB9AHPGDKDM4E | |
| SCHEMBL17592998 | 0.89 | PHGDH (0.40) | PHGDHNPC1RAB9AHPGDKDM4E | |
| SCHEMBL17593175 | 0.88 | HPGD (0.40) | NPC1RAB9AHPGDMAPTTP53 | |
| SCHEMBL17593076 | 0.85 | NPC1 (0.44) | PHGDHNPC1RAB9AHPGDKDM4E | |
| SCHEMBL17593103 | 0.85 | PHGDH (0.43) | PHGDHKDM4EMAPTCNR1 | |
| SCHEMBL17593239 | 0.84 | PHGDH (0.54) | PHGDHNPC1RAB9AHPGDMAPT | |
| SCHEMBL17593119 | 0.82 | GRM4 (0.48) | NPC1RAB9AHPGDMAPTTP53 | |
| SCHEMBL17593077 | 0.81 | NPC1 (0.37) | NPC1RAB9AHPGDKDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016040449-A1 | 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF | RAZE THERAPEUTICS, INC. (US) | 2016-03-17 | — | — | WO | disclosed |